0.00Open0.00Pre Close0 Volume0 Open Interest33.00Strike Price0.00Turnover401.72%IV-90.86%PremiumDec 20, 2024Expiry Date15.71Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8151Delta0.0281Gamma1.05Leverage Ratio-0.1793Theta-0.0048Rho-0.86Eff Leverage0.0063Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet